| Short-term costs of preeclampsia to the United States health care system W Stevens, T Shih, D Incerti, TGN Ton, HC Lee, D Peneva, GA Macones, ... American journal of obstetrics and gynecology 217 (3), 237-248. e16, 2017 | 338 | 2017 |
| R you still using excel? The advantages of modern software tools for health technology assessment D Incerti, H Thom, G Baio, JP Jansen Value in Health 22 (5), 575-579, 2019 | 52 | 2019 |
| Assessing variation in the cost of palivizumab for respiratory syncytial virus prevention in preterm infants A Shahabi, D Peneva, D Incerti, K McLaurin, W Stevens PharmacoEconomics-open 2, 53-61, 2018 | 50 | 2018 |
| Cost-effectiveness of genome sequencing for diagnosing patients with undiagnosed rare genetic diseases D Incerti, XM Xu, JW Chou, N Gonzaludo, JW Belmont, BE Schroeder Genetics in Medicine 24 (1), 109-118, 2022 | 44 | 2022 |
| Prognostic model to identify and quantify risk factors for mortality among hospitalised patients with COVID-19 in the USA D Incerti, S Rizzo, X Li, L Lindsay, V Yau, D Keebler, J Chia, L Tsai BMJ open 11 (4), e047121, 2021 | 40* | 2021 |
| Penalized regression for left‐truncated and right‐censored survival data SF McGough, D Incerti, S Lyalina, R Copping, B Narasimhan, R Tibshirani Statistics in Medicine 40 (25), 5487-5500, 2021 | 37 | 2021 |
| Hesim: health economic simulation modeling and decision analysis D Incerti, JP Jansen arXiv preprint arXiv:2102.09437, 2021 | 37* | 2021 |
| The economic burden of kidney graft failure in the United States J Sussell, AR Silverstein, P Goutam, D Incerti, R Kee, CX Chen, ... American Journal of Transplantation 20 (5), 1323-1333, 2020 | 32 | 2020 |
| Maternal and infant adverse outcomes associated with mild and severe preeclampsia during the first year after delivery in the United States TGN Ton, MV Bennett, D Incerti, D Peneva, M Druzin, W Stevens, ... American journal of perinatology 37 (04), 398-408, 2020 | 31 | 2020 |
| The lifetime health burden of delayed graft function in kidney transplant recipients in the United States D Incerti, N Summers, TGN Ton, A Boscoe, A Chandraker, W Stevens MDM policy & practice 3 (1), 2381468318781811, 2018 | 30 | 2018 |
| Incremental net monetary benefit of ocrelizumab relative to subcutaneous interferon β-1a MA Frasco, T Shih, D Incerti, O Diaz Espinosa, DK Vania, N Thomas Journal of medical economics 20 (10), 1074-1082, 2017 | 29 | 2017 |
| Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators JP Jansen, D Incerti, A Mutebi, D Peneva, JP MacEwan, B Stolshek, ... Journal of Medical Economics 20 (7), 703-714, 2017 | 29 | 2017 |
| A flexible open-source decision model for value assessment of biologic treatment for rheumatoid arthritis D Incerti, JR Curtis, J Shafrin, DN Lakdawalla, JP Jansen Pharmacoeconomics 37, 829-843, 2019 | 27 | 2019 |
| Opportunities and barriers to the development and use of open source health economic models: a survey XGLV Pouwels, CJ Sampson, RJG Arnold, MD Janodia, R Henderson, ... Value in health 25 (4), 473-479, 2022 | 23 | 2022 |
| Developing open-source models for the US health system: practical experiences and challenges to date with the open-source value project JP Jansen, D Incerti, MT Linthicum Pharmacoeconomics 37 (11), 1313-1320, 2019 | 18 | 2019 |
| Left truncation in linked data: A practical guide to understanding left truncation and applying it using SAS and R Y Jin, TGN Ton, D Incerti, S Hu Pharmaceutical Statistics 22 (1), 194-204, 2023 | 11 | 2023 |
| The optimal allocation of campaign funds in US House elections D Incerti Electoral Studies 56, 102-113, 2018 | 8 | 2018 |
| An open-source consensus-based approach to value assessment JP Jansen, D Incerti, MT Linthicum Health Affairs Forefront, 2017 | 6 | 2017 |
| Temporal patterns and adoption of germline and somatic BRCA testing in ovarian cancer SP Huepenbecker, JD Wright, MK Downer, D Incerti, P Luhn, I Dolado, ... Obstetrics & Gynecology 140 (5), 758-767, 2022 | 5 | 2022 |
| The effect of dose escalation on the cost-effectiveness of etanercept and adalimumab with methotrexate among patients with moderate to severe rheumatoid arthritis D Incerti, EJM Hernandez, J Tkacz, JP Jansen, D Collier, M Gharaibeh, ... Journal of Managed Care & Specialty Pharmacy 26 (10), 1236-1242, 2020 | 5 | 2020 |